相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Socioeconomic status and global variations in the incidence of neuroblastoma: call for support of population-based cancer registries in low-middle-income countries
Junne Kamihara et al.
PEDIATRIC BLOOD & CANCER (2017)
Advances in emerging drugs for the treatment of neuroblastoma
Pablo Berlanga et al.
EXPERT OPINION ON EMERGING DRUGS (2017)
Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial
Ruth Ladenstein et al.
LANCET ONCOLOGY (2017)
Tandem high-dose chemotherapy with thiotepa and busulfan-melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients
C. Pasqualini et al.
BONE MARROW TRANSPLANTATION (2016)
Lack of survival advantage with autologous stem-cell transplantation in high-risk neuroblastoma consolidated by anti-GD2 immunotherapy and isotretinoin
Brian H. Kushner et al.
ONCOTARGET (2016)
More than the genes, the tumor microenvironment in neuroblastoma
Lucia Borriello et al.
CANCER LETTERS (2016)
Childhood Neuroblastoma: Incidence and Survival in Argentina. Report from the National Pediatric Cancer Registry, ROHA Network 2000-2012
Florencia Moreno et al.
PEDIATRIC BLOOD & CANCER (2016)
Neuroblastoma: Molecular Pathogenesis and Therapy
Chrystal U. Louis et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Advances in Risk Classification and Treatment Strategies for Neuroblastoma
Navin R. Pinto et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Telomerase activation by genomic rearrangements in high-risk neuroblastoma
Martin Peifer et al.
NATURE (2015)
Mutational dynamics between primary and relapse neuroblastomas
Alexander Schramm et al.
NATURE GENETICS (2015)
ALK Mutations Confer Differential Oncogenic Activation and Sensitivity to ALK Inhibition Therapy in Neuroblastoma
Scott C. Bresler et al.
CANCER CELL (2014)
Immune-based therapies for childhood cancer
Crystal L. Mackall et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Does Aggressive Surgical Resection Improve Survival in Advanced Stage 3 and 4 Neuroblastoma? A Systematic Review and Meta-analysis
Dhanya Mullassery et al.
PEDIATRIC HEMATOLOGY AND ONCOLOGY (2014)
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study
Yael P. Mosse et al.
LANCET ONCOLOGY (2013)
Neuroblastoma: developmental biology, cancer genomics and immunotherapy
Nai-Kong V. Cheung et al.
NATURE REVIEWS CANCER (2013)
Outcome After Surgery Alone or With Restricted Use of Chemotherapy for Patients With Low-Risk Neuroblastoma: Results of Children's Oncology Group Study P9641
Douglas R. Strother et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
NK Cell immunotherapy for high-risk neuroblastoma relapse after haploidentical HSCT
Justyna Kanold et al.
PEDIATRIC BLOOD & CANCER (2012)
Feasibility of a tandem autologous peripheral blood stem cell transplant regimen for high risk neuroblastoma in a cooperative group setting: A Pediatric Oncology Group study: A Report from the Children's Oncology Group
Meaghan Granger et al.
PEDIATRIC BLOOD & CANCER (2012)
Changes over three decades in outcome and the prognostic influence of age-at-diagnosis in young patients with neuroblastoma: A report from the International Neuroblastoma Risk Group Project
Veronica Moroz et al.
EUROPEAN JOURNAL OF CANCER (2011)
Pilot Induction Regimen Incorporating Pharmacokinetically Guided Topotecan for Treatment of Newly Diagnosed High-Risk Neuroblastoma: A Children's Oncology Group Study
Julie R. Park et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Phase II Randomized Comparison of Topotecan Plus Cyclophosphamide Versus Topotecan Alone in Children With Recurrent or Refractory Neuroblastoma: A Children's Oncology Group Study
Wendy B. London et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Improved Survival of Children With Neuroblastoma Between 1979 and 2005: A Report of the Italian Neuroblastoma Registry
Riccardo Haupt et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Accumulation of Segmental Alterations Determines Progression in Neuroblastoma
Gudrun Schleiermacher et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma.
Alice L. Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Medical Progress: Recent Advances in Neuroblastoma.
John M. Maris
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Management and outcome of stage 3 neuroblastoma
Shakeel Modak et al.
EUROPEAN JOURNAL OF CANCER (2009)
Poor Survival for Infants With MYCN-Amplified Metastatic Neuroblastoma Despite Intensified Treatment: The International Society of Paediatric Oncology European Neuroblastoma Experience
Adela Canete et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Increasing Incidence of Neuroblastoma and Potentially Higher Associated Mortality of Children From Nonmetropolitan Areas: Analysis of the Surveillance, Epidemiology, and End Results Database
Michael H. Hsieh et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2009)
Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group
B. De Bernardi et al.
BRITISH JOURNAL OF CANCER (2008)
Localized infant neuroblastomas often show spontaneous regression: Results of the prospective trials NB95-S and NB97
Barbara Hero et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial
Andrew D. J. Pearson et al.
LANCET ONCOLOGY (2008)
Neuroblastoma incidence and survival in European children (1978-1997): Report from the Automated Childhood Cancer Information System Project
Claudia Spix et al.
EUROPEAN JOURNAL OF CANCER (2006)
Intensified external-beam radiation therapy improves the outcome of stage 4 neuroblastoma in children > 1 year with residual local disease
Thorsten Simon et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2006)
Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma
BH Kushner et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
MYCN-status in neuroblastoma:: characteristics of tumours showing amplification, gain, and non-amplification
R Spitz et al.
EUROPEAN JOURNAL OF CANCER (2004)
FISH analyses for alterations in chromosomes 1, 2, 3, and 11 define high-risk groups in neuroblastoma
R Spitz et al.
MEDICAL AND PEDIATRIC ONCOLOGY (2003)
Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification
M Kaneko et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2002)
Neuroblastoma screening at one year of age
FH Schilling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Neuroblastoma - Current drug therapy recommendations as part of the total treatment approach
F Berthold et al.
DRUGS (2000)
分享论文
